Research ArticleArticle
Dosage Adjustment of Anti-Tumor Necrosis Factor-α Inhibitor in Ankylosing Spondylitis Is Effective in Maintaining Remission in Clinical Practice
Julien Paccou, Marie-Astrid Baclé-Boutry, Elisabeth Solau-Gervais, Peggy Bele-Philippe and René-Marc Flipo
The Journal of Rheumatology June 2012, jrheum.111337; DOI: https://doi.org/10.3899/jrheum.111337
Julien Paccou
Marie-Astrid Baclé-Boutry
Elisabeth Solau-Gervais
Peggy Bele-Philippe
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Dosage Adjustment of Anti-Tumor Necrosis Factor-α Inhibitor in Ankylosing Spondylitis Is Effective in Maintaining Remission in Clinical Practice
Julien Paccou, Marie-Astrid Baclé-Boutry, Elisabeth Solau-Gervais, Peggy Bele-Philippe, René-Marc Flipo
The Journal of Rheumatology Jun 2012, jrheum.111337; DOI: 10.3899/jrheum.111337
Dosage Adjustment of Anti-Tumor Necrosis Factor-α Inhibitor in Ankylosing Spondylitis Is Effective in Maintaining Remission in Clinical Practice
Julien Paccou, Marie-Astrid Baclé-Boutry, Elisabeth Solau-Gervais, Peggy Bele-Philippe, René-Marc Flipo
The Journal of Rheumatology Jun 2012, jrheum.111337; DOI: 10.3899/jrheum.111337